Clinical trials are the best way to investigate new treatments for many conditions. Pegylated Liposomal Doxorubicin as a treatment is currently being studied in clinical trials of conditions such as Ovarian Cancer, Precancerous Condition Lymphoma, Fallopian Tube Cancer Breast Cancer and Ovarian Cancer Fallopian Tube Cancer. In the State of California, there are 63 clinical trials that use Pegylated Liposomal Doxorubicin and in Eureka, California, there are 1 Pegylated Liposomal Doxorubicin clinical trials.
Some of these are:
- Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
Clinical trials may provide patients access to the latest Pegylated Liposomal Doxorubicin that is not yet available to everyone. You may also be eligible for free medical care if you enroll in one of these active Pegylated Liposomal Doxorubicin clinical trials.